SOF/VEL
GS-US-342-1140
Phase 3 small_molecule completed
Quick answer
SOF/VEL for Hepatitis C Virus Infection is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- Hepatitis C Virus Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed